A, T., N, C., C, V., B, M., L, G., A, L., . . . O, W. (2026). MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08847-2
Chicago Style (17th ed.) CitationA, Tsakaneli, et al. "MCL1 Inhibition to Enhance the Efficacy of MYB Targeting in Pediatric Acute Myeloid Leukemia." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08847-2.
MLA (9th ed.) CitationA, Tsakaneli, et al. "MCL1 Inhibition to Enhance the Efficacy of MYB Targeting in Pediatric Acute Myeloid Leukemia." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08847-2.
Warning: These citations may not always be 100% accurate.